. | . |
Study: AI faster, better at predicting successful radiation treatment by Kyle Barnett Washington DC (UPI) Jun 3, 2021 In some scenarios, artificial intelligence is better than humans at identifying preferable outcomes for cancer radiation treatment, researchers found in a study published Thursday in Nature Medicine. Researchers at the University of Toronto found radiation treatment plans created by AI were selected over human-based treatments 72 percent of the time in a blind clinical study. In addition, the radiation treatments designed by artificial intelligence were found to be 60 percent faster than those produced by human counterparts. "We have shown that AI can be better than human judgement for curative-intent radiation therapy treatment," study co-author Christ McIntosh said in a press release. "In fact, it is amazing that it works so well," said McIntosh, chair of medical imaging and AI at the Joint Department of Medical Imaging and the University of Toronto. Researchers stressed the use of such technology is easier to control in a lab setting than in a traditional clinical setting, but expressed optimism that it will be utilized. "There has been a lot of excitement generated by AI in the lab, and the assumption is that those results will translate directly to a clinical setting," study co-author Dr. Tom Purdie said in the release. "But we sound a cautionary alert in our research that they may not," said Purdie, a radiation oncologist at the Princess Margaret Cancer Center and professor at the University of Toronto. While the results of the clinical study published in Nature Medicine could have immediate implications on radiation therapy, researchers say the technology has broader applications. Artificial intelligence is increasingly being investigated for use at improving medical diagnostics and treatment. A Finnish team recently found artificial intelligence was able to better assist in determining medication outcomes for cancer fighting agents. A German group similarly found data analysis undertaken by algorithms for X-rays and MRIs to produce more efficient diagnoses. AI has also recently been used to identify heart disease and Type 2 diabetes.
Microchip expands its range of radiation-hardened arm microcontrollers for space systems Chandler AZ (SPX) Apr 28, 2021 Deep space initiatives including planetary exploration, orbiter missions and space research require innovative spacecraft system technology providing connectivity and processing. To enable system designers better integration and higher performance while reducing development costs and time to market, COTS technologies and scalable solutions are increasingly used in space applications. Microchip Technology Inc. has announced the qualification of its SAMRH71 Arm-based microprocessor (MPU) and the availabil ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |